Jul 10, 2026 09:00AM
Apr 29, 2026 07:00AM
Apr 29, 2026 06:09AM
Apr 29, 2026 03:23AM
Apr 28, 2026 04:00PM
Mar 24, 2026 10:30AM
Mar 2, 2026 07:37AM AstraZeneca (AZN) PT Raised to $109 at Morgan Stanley
Feb 20, 2026 07:01AM
Feb 20, 2026 07:00AM
Feb 13, 2026 01:30PM
Feb 10, 2026 07:05AM
Feb 10, 2026 07:00AM
Feb 10, 2026 04:52AM
Feb 9, 2026 12:00PM AstraZeneca is set to report on Tuesday. Here's what to watch out for.
Jan 14, 2026 01:11AM
Jan 5, 2026 04:09AM
Dec 3, 2025 02:59AM
Nov 26, 2025 08:00AM
Nov 10, 2025 04:36AM
Nov 6, 2025 07:00AM
Nov 6, 2025 06:56AM AstraZeneca beats forecasts in Q3, reaffirms full-year guidance
Nov 6, 2025 05:58AM
Nov 6, 2025 12:00AM
Oct 16, 2025 07:13AM
Jul 29, 2025 07:00AM
Jul 29, 2025 05:05AM
Jul 29, 2025 02:05AM
Jun 12, 2025 07:53AM UBS identifies stock winners amid structural growth tailwinds
May 2, 2025 08:30AM
Apr 29, 2025 03:31AM
Apr 29, 2025 02:00AM
Apr 24, 2025 05:00PM
Apr 22, 2025 06:00AM
Mar 3, 2025 08:00AM
Feb 26, 2025 07:02AM AstraZeneca breast cancer drug shows positive results, shares up
Feb 14, 2025 04:30AM
Feb 12, 2025 05:45AM
Feb 10, 2025 10:00AM
Feb 10, 2025 05:32AM
Feb 6, 2025 07:00AM
Feb 6, 2025 05:14AM
Jan 17, 2025 07:00AM AstraZeneca (AZN) Reports CALQUENCE plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma
Jan 17, 2025 07:00AM
Nov 20, 2024 12:34AM
Nov 18, 2024 06:22AM
Nov 12, 2024 07:09AM
Nov 12, 2024 07:01AM
Nov 12, 2024 07:00AM
Nov 12, 2024 07:00AM AstraZeneca’s 9M and Q3 2024 results
Nov 12, 2024 03:46AM

1,204,702 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All